- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 103/30 - Rare earths
Patent holdings for IPC class A61K 103/30
Total number of patents in this class: 185
10-year publication summary
|
1
|
2
|
1
|
4
|
9
|
24
|
21
|
21
|
35
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10263 |
12 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 400 |
8 |
| Albert-ludwigs-universitat Freiburg | 389 |
7 |
| Technische Universitat Munchen | 712 |
7 |
| Advanced Accelerator Applications (Italy), S.r.l. | 22 |
7 |
| Debiopharm International SA | 137 |
5 |
| Paul Scherrer Institut | 275 |
5 |
| Merck Patent GmbH | 5725 |
4 |
| Purdue Research Foundation | 3913 |
3 |
| Advanced Accelerator Applications International S.A. | 46 |
3 |
| Ratio Therapeutics, Inc. | 21 |
3 |
| Novartis Pharma AG | 226 |
2 |
| Centre National de La Recherche Scientifique | 11016 |
2 |
| Advanced Accelerator Applications | 17 |
2 |
| Advanced Accelerator Applications USA, Inc. | 6 |
2 |
| Affibody AB | 113 |
2 |
| Centre Eugene Marquis | 9 |
2 |
| Helmholtz-Zentrum Dresden-Rossendorf e.V. | 140 |
2 |
| ITM Isotopen Technologien München AG | 18 |
2 |
| Medizinische Universitat Innsbruck | 62 |
2 |
| Other owners | 103 |